Pamir Ozan 4
4 · 180 Life Sciences Corp. · Filed May 19, 2023
Insider Transaction Report
Form 4
Pamir Ozan
Interim CFO
Transactions
- Purchase
Common Stock
2023-05-18$1.01/sh+5,162.077$5,214→ 8,983.077 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.9801 to $1.02, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.